Report cover image

Global Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Feb 11, 2025
Length 190 Pages
SKU # APRC19862448

Description

Summary

According to APO Research, The global Nicotinamide Riboside (NR) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Nicotinamide Riboside (NR) production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Nicotinamide Riboside (NR) by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Nicotinamide Riboside (NR), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nicotinamide Riboside (NR), also provides the consumption of main regions and countries. Of the upcoming market potential for Nicotinamide Riboside (NR), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Riboside (NR) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nicotinamide Riboside (NR) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nicotinamide Riboside (NR) sales, projected growth trends, production technology, application and end-user industry.


Nicotinamide Riboside (NR) Segment by Company

ChromaDex
Genex Formulas
Bontac
Tiantai Biotechnology
Zhejiang Jiahua
Shandong Tianming Pharmaceutical
Suzhou MyLand Pharm & Nutrition
EnzymeWorks
Longer Livetech
Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) Segment by Type

Purity ≤98%
Purity >98%

Nicotinamide Riboside (NR) Segment by Application

Health Supplement
Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America

United States

Canada

Mexico
Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland
Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia
South America

Brazil

Argentina

Chile
Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Riboside (NR) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Riboside (NR) industry.
Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) market competition landscape. Including Nicotinamide Riboside (NR) manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Nicotinamide Riboside (NR) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Nicotinamide Riboside (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2020-2031)
1.2.2 Global Nicotinamide Riboside (NR) Production Capacity Estimates and Forecasts (2020-2031)
1.2.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts (2020-2031)
1.2.4 Global Nicotinamide Riboside (NR) Market Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Nicotinamide Riboside (NR) Market Dynamics
2.1 Nicotinamide Riboside (NR) Industry Trends
2.2 Nicotinamide Riboside (NR) Industry Drivers
2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Nicotinamide Riboside (NR) Market by Manufacturers
3.1 Global Nicotinamide Riboside (NR) Production Value by Manufacturers (2020-2025)
3.2 Global Nicotinamide Riboside (NR) Production by Manufacturers (2020-2025)
3.3 Global Nicotinamide Riboside (NR) Average Price by Manufacturers (2020-2025)
3.4 Global Nicotinamide Riboside (NR) Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application
3.7 Global Nicotinamide Riboside (NR) Manufacturers Established Date
3.8 Market Competitive Analysis
3.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Production Value in 2024
3.8.3 2024 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Riboside (NR) Market by Type
4.1 Nicotinamide Riboside (NR) Type Introduction
4.1.1 Purity ≤98%
4.1.2 Purity >98%
4.2 Global Nicotinamide Riboside (NR) Production by Type
4.2.1 Global Nicotinamide Riboside (NR) Production by Type (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Riboside (NR) Production by Type (2020-2031)
4.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Type (2020-2031)
4.3 Global Nicotinamide Riboside (NR) Production Value by Type
4.3.1 Global Nicotinamide Riboside (NR) Production Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Riboside (NR) Production Value by Type (2020-2031)
4.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2020-2031)
5 Nicotinamide Riboside (NR) Market by Application
5.1 Nicotinamide Riboside (NR) Application Introduction
5.1.1 Health Supplement
5.1.2 Pharmaceutical Additives
5.2 Global Nicotinamide Riboside (NR) Production by Application
5.2.1 Global Nicotinamide Riboside (NR) Production by Application (2020 VS 2024 VS 2031)
5.2.2 Global Nicotinamide Riboside (NR) Production by Application (2020-2031)
5.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Application (2020-2031)
5.3 Global Nicotinamide Riboside (NR) Production Value by Application
5.3.1 Global Nicotinamide Riboside (NR) Production Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Nicotinamide Riboside (NR) Production Value by Application (2020-2031)
5.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2020-2031)
6 Company Profiles
6.1 ChromaDex
6.1.1 ChromaDex Comapny Information
6.1.2 ChromaDex Business Overview
6.1.3 ChromaDex Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
6.1.5 ChromaDex Recent Developments
6.2 Genex Formulas
6.2.1 Genex Formulas Comapny Information
6.2.2 Genex Formulas Business Overview
6.2.3 Genex Formulas Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
6.2.5 Genex Formulas Recent Developments
6.3 Bontac
6.3.1 Bontac Comapny Information
6.3.2 Bontac Business Overview
6.3.3 Bontac Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
6.3.5 Bontac Recent Developments
6.4 Tiantai Biotechnology
6.4.1 Tiantai Biotechnology Comapny Information
6.4.2 Tiantai Biotechnology Business Overview
6.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
6.4.5 Tiantai Biotechnology Recent Developments
6.5 Zhejiang Jiahua
6.5.1 Zhejiang Jiahua Comapny Information
6.5.2 Zhejiang Jiahua Business Overview
6.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
6.5.5 Zhejiang Jiahua Recent Developments
6.6 Shandong Tianming Pharmaceutical
6.6.1 Shandong Tianming Pharmaceutical Comapny Information
6.6.2 Shandong Tianming Pharmaceutical Business Overview
6.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
6.6.5 Shandong Tianming Pharmaceutical Recent Developments
6.7 Suzhou MyLand Pharm & Nutrition
6.7.1 Suzhou MyLand Pharm & Nutrition Comapny Information
6.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
6.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
6.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
6.8 EnzymeWorks
6.8.1 EnzymeWorks Comapny Information
6.8.2 EnzymeWorks Business Overview
6.8.3 EnzymeWorks Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
6.8.5 EnzymeWorks Recent Developments
6.9 Longer Livetech
6.9.1 Longer Livetech Comapny Information
6.9.2 Longer Livetech Business Overview
6.9.3 Longer Livetech Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
6.9.5 Longer Livetech Recent Developments
6.10 Shenzhen Ejion Biotechnology
6.10.1 Shenzhen Ejion Biotechnology Comapny Information
6.10.2 Shenzhen Ejion Biotechnology Business Overview
6.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2020-2025)
6.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
6.10.5 Shenzhen Ejion Biotechnology Recent Developments
7 Global Nicotinamide Riboside (NR) Production by Region
7.1 Global Nicotinamide Riboside (NR) Production by Region: 2020 VS 2024 VS 2031
7.2 Global Nicotinamide Riboside (NR) Production by Region (2020-2031)
7.2.1 Global Nicotinamide Riboside (NR) Production by Region: 2020-2025
7.2.2 Global Nicotinamide Riboside (NR) Production Forecast by Region: 2026-2031
7.3 Global Nicotinamide Riboside (NR) Production by Region: 2020 VS 2024 VS 2031
7.4 Global Nicotinamide Riboside (NR) Production Value by Region (2020-2031)
7.4.1 Global Nicotinamide Riboside (NR) Production Value by Region: 2020-2025
7.4.2 Global Nicotinamide Riboside (NR) Production Value by Region (2026-2031)
7.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2020-2031)
7.6 Regional Production Value Trends (2020-2031)
7.6.1 North America Nicotinamide Riboside (NR) Production Value (2020-2031)
7.6.2 Europe Nicotinamide Riboside (NR) Production Value (2020-2031)
7.6.3 Asia-Pacific Nicotinamide Riboside (NR) Production Value (2020-2031)
7.6.4 South America Nicotinamide Riboside (NR) Production Value (2020-2031)
7.6.5 Middle East & Africa Nicotinamide Riboside (NR) Production Value (2020-2031)
8 Global Nicotinamide Riboside (NR) Consumption by Region
8.1 Global Nicotinamide Riboside (NR) Consumption by Region: 2020 VS 2024 VS 2031
8.2 Global Nicotinamide Riboside (NR) Consumption by Region (2020-2031)
8.2.1 Global Nicotinamide Riboside (NR) Consumption by Region (2020-2025)
8.2.2 Global Nicotinamide Riboside (NR) Consumption by Region (2026-2031)
8.3 North America
8.3.1 North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.3.2 North America Nicotinamide Riboside (NR) Consumption by Country (2020-2031)
8.3.3 U.S.
8.3.4 Canada
8.3.5 Mexico
8.4 Europe
8.4.1 Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.4.2 Europe Nicotinamide Riboside (NR) Consumption by Country (2020-2031)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.5.2 Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2020-2031)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 South America
8.6.1 South America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.6.2 South America Nicotinamide Riboside (NR) Consumption by Country (2020-2031)
8.6.3 Brazil
8.6.4 Argentina
8.6.5 Chile
8.6.6 Colombia
8.7 Middle East & Africa
8.7.1 Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.7.2 Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2020-2031)
8.7.3 Egypt
8.7.4 South Africa
8.7.5 Israel
8.7.6 Türkiye
8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Nicotinamide Riboside (NR) Value Chain Analysis
9.1.1 Nicotinamide Riboside (NR) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Nicotinamide Riboside (NR) Production Mode & Process
9.2 Nicotinamide Riboside (NR) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nicotinamide Riboside (NR) Distributors
9.2.3 Nicotinamide Riboside (NR) Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.